Capital Advisors Ltd. LLC Buys 43 Shares of Humana Inc. (NYSE:HUM)

Capital Advisors Ltd. LLC boosted its holdings in Humana Inc. (NYSE:HUM) by 26.1% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 208 shares of the insurance provider’s stock after purchasing an additional 43 shares during the quarter. Capital Advisors Ltd. LLC’s holdings in Humana were worth $53,000 at the end of the most recent quarter.

A number of other hedge funds have also added to or reduced their stakes in HUM. AMF Tjanstepension AB increased its holdings in Humana by 166.8% in the third quarter. AMF Tjanstepension AB now owns 40,051 shares of the insurance provider’s stock worth $12,686,000 after purchasing an additional 25,041 shares in the last quarter. Assenagon Asset Management S.A. increased its holdings in Humana by 12.7% in the third quarter. Assenagon Asset Management S.A. now owns 4,090 shares of the insurance provider’s stock worth $1,295,000 after purchasing an additional 461 shares in the last quarter. Mirae Asset Global Investments Co. Ltd. increased its holdings in Humana by 11.1% in the third quarter. Mirae Asset Global Investments Co. Ltd. now owns 16,528 shares of the insurance provider’s stock worth $5,282,000 after purchasing an additional 1,655 shares in the last quarter. Forsta AP Fonden increased its holdings in Humana by 13.3% in the third quarter. Forsta AP Fonden now owns 24,700 shares of the insurance provider’s stock worth $7,823,000 after purchasing an additional 2,900 shares in the last quarter. Finally, DekaBank Deutsche Girozentrale increased its holdings in Humana by 7.4% in the third quarter. DekaBank Deutsche Girozentrale now owns 55,702 shares of the insurance provider’s stock worth $17,652,000 after purchasing an additional 3,862 shares in the last quarter. 92.38% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of equities research analysts have weighed in on the company. Royal Bank of Canada reiterated an “outperform” rating and issued a $283.00 target price on shares of Humana in a report on Wednesday, February 12th. Cantor Fitzgerald reissued a “neutral” rating and issued a $290.00 price objective on shares of Humana in a research note on Wednesday, February 12th. Truist Financial raised their price objective on Humana from $260.00 to $290.00 and gave the company a “hold” rating in a research note on Monday, January 6th. Piper Sandler raised their price objective on Humana from $270.00 to $288.00 and gave the company a “neutral” rating in a research note on Wednesday, January 15th. Finally, Barclays raised their price objective on Humana from $255.00 to $270.00 and gave the company an “equal weight” rating in a research note on Thursday, February 13th. Nineteen equities research analysts have rated the stock with a hold rating and five have assigned a buy rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Hold” and an average target price of $285.68.

Humana Stock Down 0.3 %

HUM stock opened at $255.02 on Tuesday. The stock’s fifty day simple moving average is $269.30 and its two-hundred day simple moving average is $288.93. The company has a current ratio of 1.76, a quick ratio of 1.76 and a debt-to-equity ratio of 0.68. Humana Inc. has a 1-year low of $213.31 and a 1-year high of $406.46. The stock has a market cap of $30.77 billion, a P/E ratio of 25.63, a P/E/G ratio of 2.05 and a beta of 0.56.

Humana (NYSE:HUM) last posted its quarterly earnings data on Tuesday, February 11th. The insurance provider reported ($2.16) earnings per share for the quarter, topping the consensus estimate of ($2.26) by $0.10. Humana had a return on equity of 11.70% and a net margin of 1.02%. Analysts expect that Humana Inc. will post 16.47 EPS for the current year.

Humana Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, April 25th. Shareholders of record on Friday, March 28th will be given a $0.885 dividend. The ex-dividend date is Friday, March 28th. This represents a $3.54 annualized dividend and a yield of 1.39%. Humana’s dividend payout ratio is currently 35.58%.

Insiders Place Their Bets

In other Humana news, insider Timothy S. Huval sold 3,703 shares of the business’s stock in a transaction on Tuesday, December 31st. The stock was sold at an average price of $256.26, for a total value of $948,930.78. Following the sale, the insider now directly owns 8,181 shares in the company, valued at $2,096,463.06. The trade was a 31.16 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Insiders own 0.32% of the company’s stock.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.